Two new organopolyphosphazenes, viz., poly[bis(3-methoxy benzyloxy) phosphazene] (POP-1) and poly[bis(4-fluoro-4′-oxybenzophenone)]phosphazene (POP-2), have been prepared by replacing chlorine atoms of dichloropolyphosphazene with 3-methoxy benzylalcohol and 4-fluoro-4′-hydroxy-benzophenone. The polymers have been characterized by Fourier tranform infrared spectroscopy (FT-IR), 1H- and 31P-nuclear magnetic resonance (NMR) spectra and thermogravimetric (TGA) analyses. The polymers have been developed as microspheres to study their controlled-release characteristics for indomethacin, an anti-inflammatory drug. Drug-loaded microspheres have been tested for in vitro release in pH 7.4 buffer media. FT-IR, 1H- and 31P-NMR data confirmed the formation of polyorganophosphazenes substituted with 3-methoxy benzylalcohol and 4-fluoro-4′-hydroxy-benzophenone. In vitro drug-release studies have indicated sustained and controlled release of indomethacin through POP microspheres.
No takes yet. Share an insight, caveat, or question.
Gudasi et al. (2007) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: